The Tihar administration arranged a video conference of Delhi Chief Minister Arvind Kejriwal with senior specialists from AIIMS during which neither "the issue of insulin was raised by Kejriwal, nor was it suggested by the doctors", prison authorities said on Saturday.
The Aam Aadmi Party (AAP) has accused the Tihar administration of denying insulin to Kejriwal, who suffers from diabetes. The party has also alleged a "conspiracy" to "kill" him.
The Tihar administration, in a statement on Sunday, said appropriate senior specialists from AIIMS provided consultation to Kejriwal through video conference on Saturday.
"After a 40-minute detailed consultation, Kejriwal was assured that there was no serious concern and was advised to continue with the prescribed medicines, which will be evaluated and reviewed regularly," a jail official said.
The video conference was organised by the Tihar Jail administration on a request by Kejriwal's wife Sunita Kejriwal. Apart from a senior specialist from the hospital, medical officers of the Tihar jail were also on the call.
The AIIMS specialist was provided with a complete record of CGM (Glucose Monitoring Sensor) and the details of diet and medicines being taken by Kejriwal.
"Neither the issue of insulin was raised by Kejriwal, nor was it suggested by the doctors," the official added.
On Friday, the Tihar jail administration submitted a report to Delhi Lt Governor V K Saxena, saying that the chief minister's health was reviewed on April 10 and April 15 by a medicine specialist who advised oral anti-diabetic drugs and it is "incorrect to state that Kejriwal was denied insulin at any point of time" during his treatment.
Kejriwal was arrested on March 21 by the Enforcement Directorate (ED) in connection with a money-laundering case linked to the Delhi government's now-scrapped excise policy. He has been lodged in Tihar jail since April 1.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)